Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

31.58
Delayed Data
As of 4:01pm ET
 -0.15 / -0.47%
Today’s Change
30.22
Today|||52-Week Range
56.46
-12.88%
Year-to-Date
Bridge Creek Capital Management LLC Buys Boeing Co, General Motors Co, Teva Pharmaceu...
11:44am / GuruFocus News - Paid Partner Content
Teva Pharmaceutical CFO Stepping Down
Apr 25 / TheStreet.com - Paid Partner Content
Teva Confirms CFO Is Leaving
Apr 26 / TheStreet.com - Paid Partner Content
Will Fresenius' $4.75 Billion Deal for Highly Coveted Akorn Spark a Bidding War?
Apr 25 / TheStreet.com - Paid Partner Content
Meyer Handelman Co Buys Enbridge, Broadridge Financial Solutions, CDK Global, Sells S...
Apr 26 / GuruFocus News - Paid Partner Content
Stocks That Fell to 3-Year Lows in the Week of April 14
Apr 22 / GuruFocus News - Paid Partner Content
Lesa Sroufe & Co Buys Banco Bilbao Vizcaya Argentaria SA, Teva Pharmaceutical Industr...
Apr 25 / GuruFocus News - Paid Partner Content
Did Pharma & Biotech M&As Pick Pace in Q1?
Apr 18 / Zacks.com - Paid Partner Content
Novartis, Amgen Divvy Global Marketing of New Migraine Drug
Apr 25 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close31.73
Today’s open31.94
Day’s range31.30 - 31.94
Volume5,029,186
Average volume (3 months)8,966,947
Market cap$32.2B
Dividend yield4.31%
Data as of 4:01pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-6.45%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+12.01%
P/E ratio451.1
Price/Sales1.59
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.29+0.71%
OASMOasmia Pharmaceutica...-0.05-2.49%
Data as of 3:59pm ET, 04/28/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)$1.05
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Yitzhak Peterburg
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts